Shifting Trends in Patient Care: From Injectable ESAs to Personalized Oral Therapies in the Anemia Drugs Market
The Anemia Drugs Market is experiencing definitive therapeutic trends that prioritize patient convenience, safety, and personalized treatment regimens. The most pronounced trend is the progressive shift away from traditional, injectable Erythropoiesis-Stimulating Agents (ESAs) towards novel, oral alternatives, most prominently the HIF-PH inhibitors. This movement reflects a strong patient and...
0 Comments 0 Shares 287 Views 0 Reviews